Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond
To access this article, please choose from the options below
PMH holds research and/or consulting agreements with Amgen, AstraZeneca, Cellectar, Genentech and ImClone.
PII: S1053-4296(08)00065-9
doi:10.1016/j.semradonc.2008.09.009
© 2009 Elsevier Inc. All rights reserved.
